Addus HomeCare (NASDAQ:ADUS) Issues Quarterly Earnings Results, Beats Estimates By $0.24 EPS

Addus HomeCare (NASDAQ:ADUS) announced its earnings results on Monday. The company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24, Briefing.com reports. The business had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The company’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 EPS.

Addus HomeCare Trading Up 2.4 %

Shares of ADUS opened at $107.09 on Thursday. The firm has a fifty day simple moving average of $99.03 and a two-hundred day simple moving average of $92.71. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $107.54. The stock has a market capitalization of $1.75 billion, a P/E ratio of 26.57, a PEG ratio of 1.94 and a beta of 0.96. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. William Blair reissued an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Bank of America lifted their price target on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday. Oppenheimer reiterated an “outperform” rating and set a $118.00 price objective on shares of Addus HomeCare in a research report on Tuesday, March 26th. Stephens reaffirmed an “overweight” rating and issued a $115.00 target price on shares of Addus HomeCare in a research note on Tuesday. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $106.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.